ATE343792T1 - Diagnostika und therapeutika für maculare degeneration - Google Patents
Diagnostika und therapeutika für maculare degenerationInfo
- Publication number
- ATE343792T1 ATE343792T1 AT00915845T AT00915845T ATE343792T1 AT E343792 T1 ATE343792 T1 AT E343792T1 AT 00915845 T AT00915845 T AT 00915845T AT 00915845 T AT00915845 T AT 00915845T AT E343792 T1 ATE343792 T1 AT E343792T1
- Authority
- AT
- Austria
- Prior art keywords
- macular degeneration
- therapeutics
- diagnostics
- arterial wall
- aneurysm
- Prior art date
Links
- 208000002780 macular degeneration Diseases 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 3
- 208000035548 disruptive behavior disease Diseases 0.000 abstract 3
- 206010002329 Aneurysm Diseases 0.000 abstract 2
- 238000010171 animal model Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/329—Diseases of the aorta or its branches, e.g. aneurysms, aortic dissection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12082299P | 1999-02-19 | 1999-02-19 | |
| US12066899P | 1999-02-19 | 1999-02-19 | |
| US12305299P | 1999-03-05 | 1999-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343792T1 true ATE343792T1 (de) | 2006-11-15 |
Family
ID=27382498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00915845T ATE343792T1 (de) | 1999-02-19 | 2000-02-22 | Diagnostika und therapeutika für maculare degeneration |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP1153302B1 (de) |
| JP (2) | JP2003506016A (de) |
| AT (1) | ATE343792T1 (de) |
| AU (2) | AU3704900A (de) |
| DE (1) | DE60031512T2 (de) |
| WO (2) | WO2001006262A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7108982B1 (en) | 1999-02-19 | 2006-09-19 | University Of Iowa Research Foundation | Diagnostics and the therapeutics for macular degeneration |
| DE10111925A1 (de) * | 2001-03-13 | 2002-10-02 | Ogham Gmbh | Herzchip |
| US7470659B2 (en) | 2001-12-07 | 2008-12-30 | The Regents Of The University Of California | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
| EP1580553A4 (de) * | 2002-11-29 | 2006-01-18 | Eisai Co Ltd | Verfahren zum testen eines elastinverdauungsprodukts und testkit, verfahren zum nachweis einer aortendissektion und nachweiskit |
| EP1522857A1 (de) * | 2003-10-09 | 2005-04-13 | Universiteit Maastricht | Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2 |
| US20050250745A1 (en) * | 2004-02-25 | 2005-11-10 | Seddon Johanna M | Biomarkers for age-related macular degeneration (AMD) |
| CA2597411C (en) | 2005-02-14 | 2014-08-12 | University Of Iowa Research Foundation | Use of complement factor h polymorphisms in treatment and diagnosis of age-related macular degeneration |
| EP1937706A4 (de) * | 2005-09-09 | 2008-10-22 | Univ Iowa Res Found | Mit altersabhängiger makulardegeneration in zusammenhang stehende biologische marker |
| JP5357746B2 (ja) | 2006-03-11 | 2013-12-04 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 末梢性の動脈疾患のためのバイオマーカーとしてのβ−２ミクログロブリン |
| JP5431151B2 (ja) | 2006-07-13 | 2014-03-05 | ユニバーシティー オブ アイオワ リサーチ ファンデーション | 血管障害および加齢黄斑変性症の治療および診断のための方法および試薬 |
| WO2008103299A2 (en) | 2007-02-16 | 2008-08-28 | Massachusetts Eye & Ear Infirmary | Methods and compositions for prognosing, detecting, and treating age-related macular degeneration |
| ES2442919T3 (es) | 2007-03-27 | 2014-02-14 | Immunovia Ab | Firma/marcadores de proteínas para la detección de adenocarcinoma |
| WO2009003142A1 (en) | 2007-06-27 | 2008-12-31 | The Board Of Trustees Of The Leland, Stanford Junior University | Beta2-microglobulin and c reactive protein (crp) as biomarkers for peripheral artery disease |
| EP2238455A4 (de) * | 2008-01-18 | 2011-03-02 | Vatrix Medical Inc | Diagnostische biomarker für gefässaneurysma |
| PY09026846A (es) | 2008-08-05 | 2015-09-01 | Novartis Ag | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5 |
| EP2509596B1 (de) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma aminosäure zur behandlung von augenerkrankungen |
| DK2521918T3 (en) * | 2010-01-08 | 2015-06-29 | Cavadis B V | DETERMINATION OF EXOSOMAL BIOMARKETS FOR PREVENTION OF CARDIOVASCULAR EVENTS |
| US20140004510A1 (en) | 2010-09-24 | 2014-01-02 | Massachusetts Eye And Ear Infirmary | Methods and compositions for prognosing and/or detecting age-related macular degeneration |
| PE20150159A1 (es) | 2011-12-21 | 2015-02-08 | Novartis Ag | Composiciones y metodos para anticuerpos que actuan sobre el factor p |
| EP2985346A4 (de) * | 2013-04-08 | 2016-05-25 | Mitsubishi Rayon Co | Mikroarray zur bewertung von augenerkrankungen und bewertungsverfahren von augenerkrankungen |
| US10274503B2 (en) * | 2013-05-08 | 2019-04-30 | Vegenics Pty Limited | Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis |
| WO2017222914A1 (en) | 2016-06-21 | 2017-12-28 | Inception 4, Inc. | Carbocyclic prolinamide derivatives |
| CN109476637B (zh) | 2016-06-21 | 2022-02-01 | 奥瑞恩眼科有限责任公司 | 杂环脯氨酰胺衍生物 |
| RU2681279C1 (ru) * | 2018-04-11 | 2019-03-05 | Анна Анатольевна Олейник | Способ выявления разновидности формы множественных аневризм сосудов головного мозга в отдаленном послеоперационном периоде |
| KR102316999B1 (ko) * | 2019-03-20 | 2021-10-26 | (주)레티마크 | 실명 유발 주요 안질환 진단용 혈액 마커 및 이를 이용한 진단 방법 |
| CA3140265A1 (en) * | 2019-06-20 | 2020-12-24 | Avihu Meir Gamliel | System and method for fluorescence imaging of biological tissues |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN115998845A (zh) * | 2020-10-26 | 2023-04-25 | 上海交通大学医学院附属第九人民医院 | 血小板反应蛋白1在制备预防和/或治疗视网膜损伤的药物中的应用 |
| CN112946274B (zh) * | 2021-02-04 | 2024-03-26 | 复旦大学 | 颅内动脉瘤诊断血清标志物以及预测颅内动脉瘤破裂潜能血清标志物 |
| CN115443947B (zh) * | 2022-10-12 | 2023-11-21 | 江苏省人民医院（南京医科大学第一附属医院） | 高血压动物模型的制备方法 |
| CN115851909B (zh) * | 2022-11-21 | 2023-09-08 | 郑州大学第一附属医院 | 检测fosb基因的试剂在制备诊断腹主动脉瘤产品的应用 |
| CN118580331B (zh) * | 2024-08-06 | 2025-01-21 | 上海先赛生物科技有限公司 | 一种用于主动脉夹层检测的蛋白抗原组合及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9304075A (es) * | 1992-07-08 | 1994-04-29 | Applied Research Systems | Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos. |
| WO1995017673A1 (en) * | 1993-12-21 | 1995-06-29 | Ocutech, Inc. | Ocular diagnostics and therapies |
| WO1997040849A1 (en) * | 1996-05-02 | 1997-11-06 | Schering Corporation | Method for treating or preventing ischemia-reperfusion injury |
-
2000
- 2000-02-22 AT AT00915845T patent/ATE343792T1/de not_active IP Right Cessation
- 2000-02-22 WO PCT/US2000/004592 patent/WO2001006262A1/en not_active Ceased
- 2000-02-22 WO PCT/US2000/004583 patent/WO2001002866A1/en not_active Ceased
- 2000-02-22 JP JP2001508612A patent/JP2003506016A/ja not_active Withdrawn
- 2000-02-22 AU AU37049/00A patent/AU3704900A/en not_active Abandoned
- 2000-02-22 EP EP00915845A patent/EP1153302B1/de not_active Expired - Lifetime
- 2000-02-22 DE DE60031512T patent/DE60031512T2/de not_active Expired - Fee Related
- 2000-02-22 JP JP2001510848A patent/JP2003504088A/ja active Pending
- 2000-02-22 AU AU37045/00A patent/AU3704500A/en not_active Abandoned
- 2000-02-22 EP EP00915841A patent/EP1153301A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE60031512D1 (de) | 2006-12-07 |
| EP1153302A1 (de) | 2001-11-14 |
| JP2003504088A (ja) | 2003-02-04 |
| WO2001006262A1 (en) | 2001-01-25 |
| WO2001002866A1 (en) | 2001-01-11 |
| EP1153301A1 (de) | 2001-11-14 |
| AU3704900A (en) | 2001-02-05 |
| AU3704500A (en) | 2001-01-22 |
| JP2003506016A (ja) | 2003-02-18 |
| EP1153302B1 (de) | 2006-10-25 |
| DE60031512T2 (de) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE343792T1 (de) | Diagnostika und therapeutika für maculare degeneration | |
| DE60136272D1 (de) | Diagnostika und therapeutika für makula degeneration erkrankungen | |
| WO2003071927A3 (en) | Diagnostics and therapeutics for macular degeneration-related disorders | |
| WO2008070137A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
| ATE526041T1 (de) | Verfahren zur hemmung okularer vorgänge | |
| WO2008137838A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
| BR0206364A (pt) | Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro | |
| ATE290375T1 (de) | Verwendung eines mittels zur verminderung des risikos kardiovaskulärer erkrankungen | |
| NO20064193L (no) | fremgangsmate for a modulere cytokinaktivitet, beslektede reagenser | |
| TW200642694A (en) | Anti-M-CSF antibody compositions | |
| MA29528B1 (fr) | Agents de fixation | |
| ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
| DE69519929D1 (de) | Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen | |
| ATE424560T1 (de) | Marker für neuromyelitis optica | |
| EP1383465A4 (de) | Akute pharmakologische verstärkung einer psychotherapie mit mitteln zur verbesserung der lern- oder konditionierungsfunktion | |
| WO2006023412A3 (en) | Biomarkers for osteoarthritis | |
| DE60125681D1 (de) | Verwendung von NMDA NR2B Antagonist zur Behandlung von Depressionen. | |
| ATE318328T1 (de) | Diagnostika und therapeutika für osteoporose | |
| ATE525976T1 (de) | Befestigung für einen stent-graft | |
| TW200602081A (en) | Vascular targets for detecting, imaging and treating neoplasia or neovasculature | |
| ATE259379T1 (de) | Fluoresceinisothiocyanat-(fitc)-sinistrin, seine herstellung und verwendung | |
| DE69934983D1 (de) | Verfahren, vorrichtung und bildgebungsmodus für tomographische bildgebung | |
| MXPA02011516A (es) | Modelo de animal transgenico de trastornos neurodegenerativos. | |
| ATE411341T1 (de) | Einen nmda rezeptor enthaltende multiprotein- komplexe und deren verwendung | |
| DE60129454D1 (de) | Wagen für einen autoklaven |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |